Tag: Clinical
-
Paris Court Ruling on Discontinued Feature Will Have Minimal Impact on Angelalign Customers
Angelalign Has Already Replaced Torque Ridges with Upgraded “Pressure Points” in EuropeSAN CLEMENTE, Calif., Oct. 16, 2026 /PRNewswire/ — Angelalign Technology Inc. (6699.HK) (“Angel”) http://www.angelaligner.com, a company driven by innovation in orthodontic clear aligner technology, said today th…
-
Continuity Biosciences Awarded $9.6 Million Grant to Advance Ultra-Long-Acting Implant for HIV Prevention
Funding supports development of a subcutaneous implant designed to deliver HIV prevention medicine for multiple years from a single placement, advancing toward an IND submission and initiation of a first-in-human Phase 1 studyBRADENTON, Fla. and SEATTLE, Oct. 14, 2026 /PRNewswire/ — Continuity Bios…
-
ArkBio Announces FDA Clearance to Initiate Phase II Trial of AK0406 for Influenza Prevention
SHANGHAI, Oct. 13, 2026 /PRNewswire/ — Shanghai Ark Biopharmaceutical Co., Ltd. (“ArkBio”) today announced that the U.S. Food and Drug Administration (FDA) has granted its investigational new drug (IND) application for AK0406, a long-acting antiviral drug-Fc conjugate (AFC), enabling the company to…
-
SPARX Global Randomized Controlled Trial by Translumina Initiated to Advance Evidence for Drug-Coated Balloons in Complex Coronary Disease
LUCERNE, Switzerland and NEW DELHI, Oct. 12, 2026 /PRNewswire/ — The SPARX Global Randomized Controlled Trial (RCT) has been officially initiated, marking the launch of the multinational randomized trial evaluating a drug-coated balloon (DCB)-first strategy against contemporary drug-eluting stents …
-
NCCN Highlights Collaborations to Improve Global Cancer Outcomes During Meetings in North America and Asia
National Comprehensive Cancer Network participates in annual conferences for the International Gynecologic Cancer Society and Philippine Society of Medical Oncology in efforts to standardize cancer treatment recommendations.MONTREAL and MANILA, Philippines, Oct. 8, 2026 /PRNewswire/ — The National …
-
Apollo Clinical Research Conclave 2026 Explores the Future of Integrated Healthcare Innovation
~ Two-day national conclave brings together 350+ delegates to reimagine futuristic clinical research through innovation, technology, and collaboration ~NEW DELHI, Oct. 7, 2026 /PRNewswire/ — Apollo Research & Innovations successfully hosted the 4th edition of its flagship event, the Apollo Clin…
-
OncoBayes progressing OB-001 to tackle ADC resistance and TKI brain penetration
LONDON, Oct. 7, 2026 /PRNewswire/ — OncoBayes, a privately held clinical-stage pharmaceutical company, today announced the successful completion of preclinical work with OB-001, demonstrating the product’s potential to tackle two major unmet needs in oncology: ADC resistance and the brain penetrati…
-
ZEISS demonstrates new digital and visual enhancements across ophthalmic workflows at AAO
ZEISS Medical Technology will showcase its latest innovations and digital technologies at AAO, including:Connected cataract workflow –ZEISS VERACITY Surgery Planner reaches 3 million surgical cases planned through cloud-based software, supporting surgical efficiency built on automation and accurate …
-
Emerald Clinical Trials Appoints Michael Stibilj as Chief Executive Officer to Lead Next Phase of Global Growth
SINGAPORE, Oct. 1, 2026 /PRNewswire/ — Emerald Clinical Trials, a leading global clinical research organization anchored in Asia-Pacific, today announced the appointment of Michael Stibilj as Chief Executive Officer, effective 1 October 2026. The appointment marks the beginning of the company’s nex…
-
Elsevier launches ClinicalKey Nursing AI, a new evidenced-based clinical AI solution built specifically for nurses
Developed to fit around nursing workflows, ClinicalKey Nursing AI gives nurses fast, traceable answers to clinical questions at the point of care.NEW YORK, Sept. 29, 2026 /PRNewswire/ — Today Elsevier announced the global launch of ClinicalKey Nursing AI, the clinical AI tool built specifically for…
Latest News
About the Author
Your reliable go-to for precise and up-to-date information!
We are dedicated to accuracy, impartiality, and providing news as it unfolds, earning the trust of a wide audience. Keep up with real-time updates on the latest events and trends.